Tau exon 6 is regulated by an intricate interplay of trans factors and cis elements, including multiple branch points

Journal of Neurochemistry

Volumn 100, Issue 2, 2007, Pages 437-445

  Wang, Junning ^a   Tse, Sze Wah ^a   Andreadis, Athena ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alternative splicing; cis regulatory elements; Cryptic splice site; Microtubule associated protein tau; Myotonic dystrophy; Trans splicing regulators

Indexed keywords

TAU PROTEIN;

ARTICLE; BRAIN; EXON; GENE CONTROL; GENETIC ANALYSIS; HUMAN; MYOTONIC DYSTROPHY; NERVOUS SYSTEM; PRIORITY JOURNAL; REGULATORY SEQUENCE; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EXONS; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA, MESSENGER; TAU PROTEINS; TRANS-ACTIVATORS;

MAMMALIA;

EID: 33845783753     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04252.x     Document Type: Article

References (35)

1. Andreadis A. (2005) Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta 1739, 91-103.
2. Andreadis A., Brown W. M. and Kosik K. (1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10 626-10 633.
3. Andreadis A., Nisson P., Kosik K. S. and Watkins P. (1993) The exon trapping assay partly discriminates against alternatively spliced exons. Nucleic Acids Res. 21, 2217-2221.
4. Black D. L. (2003) Mechanisms of alternative pre-mRNA splicing. Annu. Rev. Biochem. 72, 291-336.
5. Blencowe B. J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110.
6. Brandt R., Hundelt M. and Shahani N. (2005) Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim. Biophys. Acta 1739, 331-354.
7. Brook J. D., McCurrach M. E., Harley H. G. et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799-808.
8. Dreyfuss G., Kim V. N. and Kataoka N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3, 195-205.
9. Fardaei M., Rogers M. T., Thorpe H. M., Hamshere M. G. and Harper P. S. and. Brook J. D. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11, 805-814.
10. Goedert M. and Jakes R. (2005) Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta 1739, 240-250.
11. Graveley B. R. (2000) Sorting out the complexity of SR protein functions. RNA 6, 1197-1211.
12. Hanamura A., Cáceres J. F., Mayeda A., Franza B. R. Jr and Krainer A. R. (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.
13. Hartmuth K. and Barta A. (1988) Unusual branch point selection in processing of human growth hormone pre-mRNA. Mol. Cell Biol. 8, 2011-2020.
14. Hofmann Y. and Wirth B. (2002) hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1. Hum. Mol. Genet. 11, 2037-2049.
15. Jiang H., Mankodi A., Swanson M. S., Moxley R. T. and Thornton C. A. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13, 3079-3088.
16. Johnson J. M., Castle J., Garrett-Engele P., Kan Z., Loerch P. M., Armour C. D., Santos R., Schadt E. E., Stoughton R. and Shoemaker D. D. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141-2144.
17. Kamma H., Portman D. S. and Dreyfuss G. (1995) Cell type-specific expression of hnRNP proteins. Exp. Cell Res. 221, 187-196.
18. Kempf M., Clement A., Faissner A., Lee G. and Brandt R. (1996) Tau bind to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J. Neurosci. 16, 5583-5592.
19. Leroy O., Wang J., Maurage C. A., Parent M., Cooper T., Buee L., Sergeant N., Andreadis A. and Caillet-Boudin M. L. (2006) Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochim. Biophys. Acta 1762, 460-467.
20. Lipscombe D. (2005) Neuronal proteins custom designed by alternative splicing. Curr. Opin. Neurobiol. 15, 358-363.
21. Luo M. H., Leski M. L. and Andreadis A. (2004a) Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation. J. Cell Biochem. 91, 880-895.
22. Luo M. H., Tse S. W., Memmott J. and Andreadis A. (2004b) Novel isoforms of tau that lack the microtubule-binding domain. J. Neurochem. 90, 340-351.
23. Modoni A., Silvestri G., Pomponi M. G., Mangiola F., Tonali P. A. and Marra C. (2004) Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch. Neurol. 61, 1943-1947.
24. Nasim M. T., Chernova T. K., Chowdhury H. M., Yue B. G. and Eperon I. C. (2003) HnRNP G and Tra2β: opposite effects on splicing matched by antagonism in RNA binding. Hum. Mol. Genet. 12, 1337-1348.
25. Nuñez J. and Fischer I. (1997) Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration. J. Mol. Neurosci. 8, 207-222.
26. Pozzoli U. and Sironi M. (2005) Silencers regulate both constitutive and alternative splicing events in mammals. Cell. Mol. Life Sci. 62, 1579-1604.
27. Schaal T. D. and Maniatis T. (1997) Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol. Cell Biol. 19, 1705-1719.
28. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C. A., Wattez A., Vermersch P. and Delacourte A. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10, 2143-2155.
29. Soller M. (2006) Pre-messenger RNA processing and its regulation: a genomic perspective. Cell Mol. Life Sci. 63, 96-819.
30. Spellman R., Rideau A., Matlin A., Gooding C., Robinson F., McGlincy N., Grellscheid S. N., Southby J., Wollerton M. and Smith C. W. (2005) Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans. 33, 457-460.
31. Timchenko N. A., Cai Z. J., Welm A. L., Reddy S. and Aschenko L. T. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 276, 7820-7826.
32. Wang J., Gao Q. S., Wang Y., Lafyatis R., Stamm S. and Andreadis A. (2004) Tau exon 10, whose mis-splicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J. Neurochem. 88, 1078-1090.
33. Wang Y., Wang J., Gao L., Lafyatis R., Stamm S. and Andreadis A. (2005) Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c. SRp55 complex that either recruits or antagonizes htra2β1. J. Biol. Chem. 280, 14 230-14 239.
34. Wei M.-L. and Andreadis A. (1998) Splicing of a regulated exon reveals additional complexity in the axonal MAP tau. J. Neurochem. 70, 1346-1356.
35. Wei M.-L., Memmott J., Screaton G. and Andreadis A. (2000) The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron. Brain Res. Mol. Brain Res. 80, 207-218.